These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 162520)

  • 41. Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects.
    Schüle C; Baghai T; Laakmann G
    Neuroendocrinology; 2004 Jan; 79(1):54-62. PubMed ID: 14755134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutamic acid decarboxylase and gamma-aminobutyric acid in Huntington's disease fibroblasts and other cultured cells, determined by a [3H]muscimol radioreceptor assay.
    Hamel E; Goetz IE; Roberts E
    J Neurochem; 1981 Oct; 37(4):1032-8. PubMed ID: 6275031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans.
    Takahara J; Yunoki S; Yakushiji W; Yamauchi J; Yamane Y
    J Clin Endocrinol Metab; 1977 May; 44(5):1014-7. PubMed ID: 858775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroendocrine tests during treatment with neuroleptic drugs. III. Plasma growth hormone and prolactin responses to apomorphine.
    Kolakowska T; Gelder M; Fraser S
    Br J Psychiatry; 1981 Nov; 139():408-12. PubMed ID: 6120733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic anticonvulsant effects of a GABA agonist and glycine.
    Seiler N; Sarhan S
    Gen Pharmacol; 1984; 15(4):367-9. PubMed ID: 6489732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth hormone response to sodium valproate in chronic schizophrenia.
    Monteleone P; Maj M; Iovino M; Steardo L
    Biol Psychiatry; 1986 Jun; 21(7):588-94. PubMed ID: 3085738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man.
    Cavagnini F; Invitti C; Pinto M; Maraschini C; Di Landro A; Dubini A; Marelli A
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):149-54. PubMed ID: 7376786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
    J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid.
    Gerra G; Caccavari R; Fontanesi B; Marcato A; Fertonani Affini G; Maestri D; Avanzini P; Lecchini R; Delsignore R; Mutti A
    Int Clin Psychopharmacol; 1994 Sep; 9(3):211-5. PubMed ID: 7814832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulatory interactions between norepinephrine and taurine, beta-alanine, gamma-aminobutyric acid and muscimol, applied iontophoretically to cerebellar Purkinje cells.
    Yeh HH; Moises HC; Waterhouse BD; Woodward DJ
    Neuropharmacology; 1981 Jun; 20(6):549-60. PubMed ID: 6787452
    [No Abstract]   [Full Text] [Related]  

  • 51. Neuropharmacological spectrum of muscimol.
    Worms P; Depoortere H; Lloyd KG
    Life Sci; 1979 Aug; 25(7):607-14. PubMed ID: 574181
    [No Abstract]   [Full Text] [Related]  

  • 52. Deficits in manipulative behaviors induced by local injections of muscimol in the first somatosensory cortex of the conscious monkey.
    Hikosaka O; Tanaka M; Sakamoto M; Iwamura Y
    Brain Res; 1985 Jan; 325(1-2):375-80. PubMed ID: 3978429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroleptic-induced prolactin rise: influence of pharmacological alterations of different neurotransmitter system.
    Chieli T; Cocchi D; Fregnan GB; Müller EE
    Experientia; 1980 Apr; 36(4):463-5. PubMed ID: 7379927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of sodium-free media on gamma-aminobutyrate and muscimol-evoked conductance increases recorded from lobster muscle fibres.
    Constanti A; Nistri A
    Neuroscience; 1981; 6(7):1443-53. PubMed ID: 7266874
    [No Abstract]   [Full Text] [Related]  

  • 55. Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia.
    Monteleone P; Zontini G; Steardo L
    Psychoneuroendocrinology; 1985; 10(4):475-80. PubMed ID: 3003777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation of growth hormone secretion by desimipramin and chlorimipramin in man.
    Laakmann G; Schumacher G; Benkert O
    J Clin Endocrinol Metab; 1977 May; 44(5):1010-3. PubMed ID: 870511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma growth hormone concentrations in Huntington's chorea.
    Phillipson OT; Bird ED
    Clin Sci Mol Med; 1976 Jun; 50(6):551-4. PubMed ID: 132332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitory effects of substance P on the gamma-amino-butyric acid and gamma-hydroxybutyric acid-induced growth hormone and prolactin release in male rats.
    Takahara J; Yunoki S; Yamauchi J; Yakushiji W; Hashimoto K; Ofuji T
    Life Sci; 1981 Sep; 29(12):1229-31. PubMed ID: 6170854
    [No Abstract]   [Full Text] [Related]  

  • 59. EMD 23,448: effects of a putative dopamine autoreceptor agonist in chorea.
    Newman RP; Tamminga CA; Chase TN; LeWitt PA
    J Neural Transm; 1985; 61(1-2):125-9. PubMed ID: 3156964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin response to beta-endorphin in man.
    Schulz SC; Wagner B; van Kammen DP; Rogol AD; Davis GC; Wyatt RJ; Pickar D; Bunney WE; Li CH
    Life Sci; 1980 Nov; 27(19):1735-41. PubMed ID: 7464447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.